SCHEMBL7425542

SCHEMBL7425542

COc1ccc(S(=O)(=O)NCc2ccco2)cc1OC

nearest known ligand 0.77

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.69
KMT2A Q03164 5/20 0.69
MEN1 O00255 4/20 0.69
MAPT P10636 3/20 0.69
POLB P06746 2/20 0.69
RECQL P46063 2/20 0.69
USP2 O75604 1/20 0.69
TDP1 Q9NUW8 1/20 0.69
KDM4E B2RXH2 2/20 0.69
LMNA P02545 3/20 0.62
MAPK1 P28482 2/20 0.62
NPSR1 Q6W5P4 2/20 0.62
SMN1; SMN2 Q16637 2/20 0.62
TSHR P16473 2/20 0.58
HPGD P15428 1/20 0.58
HSD17B10 Q99714 1/20 0.58
GAA P10253 1/20 0.58
PKM P14618 1/20 0.58
HTT P42858 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7419855 0.93 POLB (0.62) ALDH1A1KMT2AMEN1MAPTPOLB
SCHEMBL7427816 0.87 PDE4A (0.59) ALDH1A1KMT2AMEN1MAPTPOLB
SCHEMBL7418279 0.87 NPSR1 (0.62) ALDH1A1KMT2AMEN1MAPTPOLB
SCHEMBL15831619 0.86 KMT2A (0.68) ALDH1A1KMT2AMEN1MAPTPOLB
SCHEMBL7422586 0.79 ALDH1A1 (0.60) ALDH1A1KMT2AMEN1MAPTPOLB
SCHEMBL7415584 0.78 SMN1; SMN2 (0.78) ALDH1A1KMT2AMAPTPOLBLMNA
SCHEMBL13297941 0.77 KMT2A (0.91) ALDH1A1KMT2AMEN1MAPTPOLB
SCHEMBL12793686 0.77 KMT2A (0.72) ALDH1A1KMT2AMEN1MAPTPOLB
SCHEMBL4182162 0.77 KMT2A (0.77) ALDH1A1KMT2APOLBLMNAMAPK1
SCHEMBL11554210 0.77 ALDH1A1 (0.54) ALDH1A1KMT2AMEN1MAPTPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1996036595-A1 3,4-DISUBSTITUTED-PHENYLSULPHONAMIDES AND THEIR THERAPEUTIC USE CHIROSCIENCE LIMITED (GB) 1996-11-21 WO disclosed